7Baggers

Tyra Biosciences . Quarterly Cash Flow Statements Chart

Quarterly
 | 
Annual
 
 Operating Cashflow  
 Investing Cashflow  
 Financing Cashflow  
 Capital Expenditure  
20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 -144.44-97.6-50.76-3.9242.9289.76136.6183.44Milllion

Tyra Biosciences . Quarterly Cash Flow Statements Table

Quarterly
 | 
Annual
 
Unit: USD2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 
  net cash from operating activities-13,532,000 -17,145,000 -9,615,000 -9,847,000 -11,980,000 -12,212,000 -17,168,000 -8,925,000 -9,028,000 -5,578,000 
  net cash from investing activities-144,438,000 -83,000 -43,000 -41,000 -21,000 -48,000 -251,000 -239,000 -105,000 -240,000 
  net cash from financing activities324,000 467,000 370,000 376,000 3,000 364,000 27,000 238,000 -1,508,000 183,437,000 
  capital expenditure-603,000 -83,000 -43,000 -41,000 -21,000 -48,000 -251,000 -239,000 -105,000 -256,000 

We provide you with 20 years of cash flow statements for Tyra Biosciences . stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Tyra Biosciences . stock. Explore the full financial landscape of Tyra Biosciences . stock with our expertly curated income statements.

The information provided in this report about Tyra Biosciences . stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.